Ute Schellenberger

Years Active: 2019-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Brian C Avanzino, Kirthana Prabhakar, Pranjali Dalvi, Sharon Hartstein, Hannes Kehm, Aarti Balasubramani, Andrew A Boudreau, Ben Buelow, Karen Chang, Laura M Davison, Suhasini Iyer, Vidyut Kalwit, Kristin Lewis Wilson, Harbani K Malik-Chaudhry, Will Pierson, Geovanni Pineda, Udaya S Rangaswamy, Sowmya Saiganesh, Ute Schellenberger, Harshad S Ugamraj, Rodolfovan D Yabut, Roland Buelow, Jocelyn Chapman, Nathan D Trinklein, Katherine E Harris
A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer. Oncoimmunology 11 (1) (2022)
Harbani K Malik-Chaudhry, Kirthana Prabhakar, Harshad S Ugamraj, Andrew A Boudreau, Benjamin Buelow, Kevin Dang, Laura M Davison, Katherine E Harris, Brett Jorgensen, Heather Ogana, Duy Pham, Ute Schellenberger, Wim Van Schooten, Roland Buelow, Suhasini Iyer, Nathan D Trinklein, Udaya S Rangaswamy
TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL. mAbs 13 (1) (2022)
Nathan D Trinklein, Duy Pham, Ute Schellenberger, Ben Buelow, Andrew A Boudreau, Priya Choudhry, Starlynn C Clarke, Kevin Dang, Katherine E Harris, Suhasini Iyer, Brett Jorgensen, Payal P Pratap, Udaya S Rangaswamy, Harshad S Ugamraj, Omid Vafa, Arun P Wiita, Wim van Schooten, Roland Buelow, Shelley Force Aldred
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies. mAbs 11 (4) (2019)

Ute Schellenberger.css-eqlu8i{font-size:small;padding-left:4px;}